| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |